2025 Speakers
Jeremy Abbate
Scientific American
Edwin Addison
QPMind
Erkang Ai
Hogan Lovells
Virginia Amann
ENTENTE Network
Bea Bakshi
C the Signs
Frank Bedu-Addo
PDS Biotechnology Corporation
Robert Arch
Immunophotonics, Inc.
Stacy Blain
Concarlo Therapeutics Inc.
Jennifer Hawks Bland
NewYorkBIO
Komal Bajaj
NYC Health + Hospitals (Jacobi/NCB)
Max Bayer
Endpoints News
Bigyan Bista
Enveda
Jay Campbell
Life Sciences Executive, CBO, CFO, & Advisory Board Member
Maria Carney
Northwell Health
Ahmet-Hamdi Çavuşoğlu
Merck Digital Sciences Studio
Gerald Commissiong
OS Therapies, Inc.
John Coster
Centers for Medicare and Medicaid Services (former)
Alice Valder Curran
Hogan Lovells
Milad Dagher
Nomic Bio
Daniel Delubac
iORGANBIO
David Ewing Duncan
Author, Journalist & Entrepreneur
E. Cartier Esham
Esham Strategies
Tala Fakhouri
Parexel
Jessica Federer
Angelini Ventures
Mike Fisher
Oncimmune
Kirsten Flowers
Chiara Biosciences, Inc
James Flynn
Deerfield Management
Vitalay Fomin
Numenos
David Foster
Island Pharmaceuticals Ltd.
Julie Frearson
Charles River Laboratories
Nicholas Geisse
Curi Bio, Inc.
Alice Gilman
R3 Biotechnologies
Connor Glass
Phantom Neuro
Gautam Goel
Aetherium Bio
Roger Hajjar
Mass General Brigham
Shelley Hartman
Aegle Therapeutics Corporation
Echo Hindle-Yang
MSQ Ventures
Beth Hoffman
Origami Therapeutics, Inc.
Nouhad Husseini
Regeneron Pharmaceuticals
Thomas Ichim
Immorta Bio
Ginger Johnson
Lumanity
Marc Jones
Altoida, Inc.
Konstantina Katcheves
Acadia Pharmaceuticals
Hans Keirstead
Immunis, Inc.
Bogdan Knezevic
Kaleidoscope.bio
Richard Kornbluth
Multimeric Biotherapeutics, Inc.
Akhila Kosaraju
Phare Bio
Filipp Kramer
Alchemy Bio
Daniella Kranjac
Avant Bio
Michael Langer
T.Rx Capital
Sebastien Latapie
Avant Bio
Yeji Jesse Lee
Law360
Raven Lin
Pilatus Biosciences
Neal Masia
EntityRisk, Inc.
Jeffrey Meckler
Indaptus Therapeutics
Shreefāl Mehta
Repoxegen Therapeutics Inc.
Michael Meyers
H.C. Wainwright & Co., LLC
Michael Montgomery
Tidewave Bio
Nancy Myers
Catalyst Healthcare Consulting
Jo Natauri
Invidia Capital Management
Tim Opler
Stifel
Julie O’Shaughnessy
Vivodyne
David Pass
AltrixBio Inc.
Michael D. Patten
Harbour BioMed
Kelliann Payne
Hogan Lovells
Bernard Peperstraete
Acuamark Diagnostics, Inc.
Viq Pervaaz
NYCEDC
Dan Que Pham
Oncodea
Alex Philippidis
Genetic Engineering & Biotechnology News (GEN)
Maria Luisa Pineda
Envisagenics
Aayushi Pratap
American Chemical Society
Dennis Purcell
Aisling Capital
Umer Raffat
Evercore ISI
Priyanka Rao
Rackhouse Venture Capital
Rachel Ravens
46Health
Dayton Reardan
Niche Biopharmaceuticals, LLC
MaryAnne Rizk
Amazon Web Services
Adam Rogers
NervGen Pharma
Beth Rogozinski
Oncoustics
Irene Rombel
BioCurie
Philip Ross
Jefferies
Peter Rubin
No Patient Left Behind
Eric Schmidt
Cantor Fitzgerald
Jennifer Schranz
Ipsen
David Schull
Russo Partners
Stacey Seltzer
Pontiva Healthcare Partners
Melindah Sharma
Manatt Health
Rachel Sher
Manatt Health
Greg Simon
Former Director, White House Cancer Moonshot
Rachel Sparks
Yale University
Arun Swaminathan
Coya Therapeutics, Inc.
Daniel Teper
Naya Therapeutics
Wenzhi Tian
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Ashish Tripathi
Tzar Labs
John Tsang
Yale University
Arda Ural
Ernst & Young LLP
Brent Vaughan
Eratos Therapeutics
Chris Vlahos
Acadia Pharmaceuticals
Michael Webb
Epion Therapeutics, Inc.
Ignacio Willats
Mytos
Brenda Wu
Teva Pharmaceuticals
Ming-Ru Wu
TroGen Therapeutics
Luke Yu
Crown Bioscience
Lihua Zheng
Z-Star Therapeutics Inc.